Nobel Biocare posts disappointing results

Dental implant maker Nobel Biocare has reported a fall in net profit by one third in 2008 to €109.7 million (SFr164.3 million), with turnover down 4.2 per cent.

This content was published on February 11, 2009

The Zurich-based firm, which is the world leader in its sector, missed expectations as cash-strapped customers continued to cut spending on its top-of-the-range treatments.

The group, which also makes bridges and crowns, reported a turnover of €619.2 million, down from €665.9 million in 2007.

In a statement on Wednesday, Nobel Biocare said it could not give a reliable outlook for 2009.

"For 2009, the company continues to foresee a demanding market environment due to deteriorating economic conditions in most markets."

The company is in the process of reducing its overall workforce by around three per cent although it still employs more people than in 2007 following three acquisitions last year.

In compliance with the JTI standards

In compliance with the JTI standards

More: SWI certified by the Journalism Trust Initiative

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Discover our weekly must-reads for free!

Sign up to get our top stories straight into your mailbox.

The SBC Privacy Policy provides additional information on how your data is processed.